Developing Targeted Therapy for Patients with Multiple Myeloma and Gain or Amplification of Chr1q (1q+)
Demographics (3)
- AGE - Patients age at sample collection (phv00556532.v1.p1)
- COLLECTION_AGE - Patients age at sample collection (phv00556541.v1.p1)
- SEX - Biological sex (phv00556528.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00556533.v1.p1)
Other (15)
- ANALYTE_TYPE - Analyte Type (phv00556539.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00556536.v1.p1)
- CONSENT - Type of consent (phv00556527.v1.p1)
- DATA_TYPE - Type of assay performed (phv00556537.v1.p1)
- DIAGNOSIS - Smoldering Multiple Myeloma (SMM) or Monoclonal gammopathy of undetermined significance (MGUS) (phv00556534.v1.p1)
- IS_TUMOR - Tumor status (phv00556540.v1.p1)
- SAMPLE_ID - Sample ID (phv00556535.v1.p1)
- SAMPLE_ID - Sample ID (phv00556530.v1.p1)
- SOURCE_SAMPLE_NAME - Sample ID in overlapping project phs001323.v3.p1 (phv00556794.v1.p1)
- SOURCE_SUBJECT_ID - Subject ID used in the Source Repository phs001323.v3.p1 (phv00556793.v1.p1)
- SUBJECT_ID - Subject ID (phv00556526.v1.p1)
- SUBJECT_ID - Subject ID (phv00556531.v1.p1)
- SUBJECT_ID - Subject ID (phv00556529.v1.p1)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00556792.v1.p1)
- TREATMENT_TYPE - Type of treatment administered (phv00556538.v1.p1)